Peapack-Gladstone Financial Corp’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,230	Closed	-$36K	–	715
2023 Q4	$36K	Hold	5,230	–	–	﹤0.01%	691
2023 Q3	$33K	Hold	5,230	–	–	﹤0.01%	685
2023 Q2	$43K	Buy	+5,230	New	+$43K	﹤0.01%	696